Market Tracker

09/27 5:16pm ET

CASI Pharmaceuticals Inc (NASDAQ:CASI)

1.16
Delayed Data
As of 3:59pm ET
 -0.0067 / -0.57%
Today’s Change
0.58
Today|||52-Week Range
1.82
+20.83%
Year-to-Date
No recent news for CASI Pharmaceuticals Inc.

Today’s Trading

Previous close1.17
Today’s open1.15
Day’s range1.15 - 1.21
Volume5,034
Average volume (3 months)41,983
Market cap$57.7M
Dividend yield--
Data as of 3:59pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)+76.09%
Earnings growth (this year)-27.27%
Earnings growth (next 5 years)--
Revenue growth (last year)+101.09%
P/E ratioNM
Price/Sales652.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EBIOEleven Biotherapeuti...+0.16+5.57%
OCRXOcera Therapeutics I...0.000.00%
GLMDGalmed Pharmaceutica...-0.10-1.89%
XOMAXOMA Corp-0.01-2.88%
Data as of 3:59pm ET, 09/27/2016

Financials

Next reporting dateNovember 11, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$47.7K
Annual profit (last year)-$7.2M
Net profit margin-15,104.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ken Keyong Ren
COO, Secretary, Vice President &
General Counsel
Cynthia Wong Hu
Corporate headquarters
Rockville, Maryland

Forecasts